Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction

Christopher J. Wingard, John A Johnson, Andre Holmes, Anita Prikosh

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Androgens are reported to act as strong modulators of erectile function influencing both nitric oxide and vasoconstrictor signaling. Castration results in a depressed erectile response that is associated with a loss of nitric oxide production and increased responsiveness to constrictive agents. The increased vasoconstrictor response may be a result of an active RhoA/Rho-kinase signaling pathway. We report here results of studies designed to test the hypothesis that inhibition of the Rho-kinase pathway restores erectile function in a castrate model by relaxing the smooth muscle. Mean arterial (MAP) and corpus cavernosal (CCP) pressures were monitored during intracavernosal injection of the Rho-kinase inhibitor Y-27632. Castration reduced the maximal erectile response (CCP/MAP) by 33%, and testosterone replacement restored the response (intact, 0.736 ± 0.040; castrate, 0.492 ± 0.022; testosterone, 0.681 ± 0.073). Injection of Y-27632 increased CCP in all experimental groups; it also left shifted the voltage response curve and increased the maximal CCP/MAP response (intact, 0.753 ± 0.091; castrate, 0.782 ± 0.081; testosterone treated, 0.894 ± 0.033). Y-27632 dose dependently relaxed phenylephrinestimulated cavernosal tissues. Cavernosal tissues showed increased RhoA and Rho-kinase protein levels after castration. Our data support the hypothesis that an active Rho/Rho-kinase pathway contributes to the reduced erectile response after castration due to an upregulation of RhoA/Rho-kinase protein levels and that inhibition of this pathway may serve as an effective treatment for erectile dysfunction.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume284
Issue number6 53-6
StatePublished - Jun 1 2003

Fingerprint

rho-Associated Kinases
Erectile Dysfunction
Castration
Testosterone
Vasoconstrictor Agents
Nitric Oxide
Injections
Androgens
Smooth Muscle
Inhibition (Psychology)
Proteins
Up-Regulation
Pressure
Y 27632

Keywords

  • Corpus cavernosum
  • Phenylephrine
  • RhoA
  • Smooth muscle contraction
  • Testosterone

ASJC Scopus subject areas

  • Physiology

Cite this

Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction. / Wingard, Christopher J.; Johnson, John A; Holmes, Andre; Prikosh, Anita.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 284, No. 6 53-6, 01.06.2003.

Research output: Contribution to journalArticle

@article{63bb597b7a4f4bf8a7bcc70106ab7588,
title = "Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction",
abstract = "Androgens are reported to act as strong modulators of erectile function influencing both nitric oxide and vasoconstrictor signaling. Castration results in a depressed erectile response that is associated with a loss of nitric oxide production and increased responsiveness to constrictive agents. The increased vasoconstrictor response may be a result of an active RhoA/Rho-kinase signaling pathway. We report here results of studies designed to test the hypothesis that inhibition of the Rho-kinase pathway restores erectile function in a castrate model by relaxing the smooth muscle. Mean arterial (MAP) and corpus cavernosal (CCP) pressures were monitored during intracavernosal injection of the Rho-kinase inhibitor Y-27632. Castration reduced the maximal erectile response (CCP/MAP) by 33{\%}, and testosterone replacement restored the response (intact, 0.736 ± 0.040; castrate, 0.492 ± 0.022; testosterone, 0.681 ± 0.073). Injection of Y-27632 increased CCP in all experimental groups; it also left shifted the voltage response curve and increased the maximal CCP/MAP response (intact, 0.753 ± 0.091; castrate, 0.782 ± 0.081; testosterone treated, 0.894 ± 0.033). Y-27632 dose dependently relaxed phenylephrinestimulated cavernosal tissues. Cavernosal tissues showed increased RhoA and Rho-kinase protein levels after castration. Our data support the hypothesis that an active Rho/Rho-kinase pathway contributes to the reduced erectile response after castration due to an upregulation of RhoA/Rho-kinase protein levels and that inhibition of this pathway may serve as an effective treatment for erectile dysfunction.",
keywords = "Corpus cavernosum, Phenylephrine, RhoA, Smooth muscle contraction, Testosterone",
author = "Wingard, {Christopher J.} and Johnson, {John A} and Andre Holmes and Anita Prikosh",
year = "2003",
month = "6",
day = "1",
language = "English (US)",
volume = "284",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 53-6",

}

TY - JOUR

T1 - Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction

AU - Wingard, Christopher J.

AU - Johnson, John A

AU - Holmes, Andre

AU - Prikosh, Anita

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Androgens are reported to act as strong modulators of erectile function influencing both nitric oxide and vasoconstrictor signaling. Castration results in a depressed erectile response that is associated with a loss of nitric oxide production and increased responsiveness to constrictive agents. The increased vasoconstrictor response may be a result of an active RhoA/Rho-kinase signaling pathway. We report here results of studies designed to test the hypothesis that inhibition of the Rho-kinase pathway restores erectile function in a castrate model by relaxing the smooth muscle. Mean arterial (MAP) and corpus cavernosal (CCP) pressures were monitored during intracavernosal injection of the Rho-kinase inhibitor Y-27632. Castration reduced the maximal erectile response (CCP/MAP) by 33%, and testosterone replacement restored the response (intact, 0.736 ± 0.040; castrate, 0.492 ± 0.022; testosterone, 0.681 ± 0.073). Injection of Y-27632 increased CCP in all experimental groups; it also left shifted the voltage response curve and increased the maximal CCP/MAP response (intact, 0.753 ± 0.091; castrate, 0.782 ± 0.081; testosterone treated, 0.894 ± 0.033). Y-27632 dose dependently relaxed phenylephrinestimulated cavernosal tissues. Cavernosal tissues showed increased RhoA and Rho-kinase protein levels after castration. Our data support the hypothesis that an active Rho/Rho-kinase pathway contributes to the reduced erectile response after castration due to an upregulation of RhoA/Rho-kinase protein levels and that inhibition of this pathway may serve as an effective treatment for erectile dysfunction.

AB - Androgens are reported to act as strong modulators of erectile function influencing both nitric oxide and vasoconstrictor signaling. Castration results in a depressed erectile response that is associated with a loss of nitric oxide production and increased responsiveness to constrictive agents. The increased vasoconstrictor response may be a result of an active RhoA/Rho-kinase signaling pathway. We report here results of studies designed to test the hypothesis that inhibition of the Rho-kinase pathway restores erectile function in a castrate model by relaxing the smooth muscle. Mean arterial (MAP) and corpus cavernosal (CCP) pressures were monitored during intracavernosal injection of the Rho-kinase inhibitor Y-27632. Castration reduced the maximal erectile response (CCP/MAP) by 33%, and testosterone replacement restored the response (intact, 0.736 ± 0.040; castrate, 0.492 ± 0.022; testosterone, 0.681 ± 0.073). Injection of Y-27632 increased CCP in all experimental groups; it also left shifted the voltage response curve and increased the maximal CCP/MAP response (intact, 0.753 ± 0.091; castrate, 0.782 ± 0.081; testosterone treated, 0.894 ± 0.033). Y-27632 dose dependently relaxed phenylephrinestimulated cavernosal tissues. Cavernosal tissues showed increased RhoA and Rho-kinase protein levels after castration. Our data support the hypothesis that an active Rho/Rho-kinase pathway contributes to the reduced erectile response after castration due to an upregulation of RhoA/Rho-kinase protein levels and that inhibition of this pathway may serve as an effective treatment for erectile dysfunction.

KW - Corpus cavernosum

KW - Phenylephrine

KW - RhoA

KW - Smooth muscle contraction

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=0013198310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013198310&partnerID=8YFLogxK

M3 - Article

VL - 284

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 6 53-6

ER -